Skip to main content

Table 1 Clinical characteristics of study participants (n = 32) with DNA methylation data both before (baseline) and after the intervention

From: Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation

Variables

Ex (n = 8)

LCD (n = 8)

ELCD (n = 9)

No (n = 7)

Within Groups (p value)

Baseline

Intervention

Baseline

Intervention

Baseline

Intervention

Baseline

Intervention

Ex

Diet

Ex + Diet

No

HFC (%)

23.6 (11.0)

11.0 (5.5)

17.2 (13.6)

11.0 (13.2)

19.2 (11.1)

6.7 (4.1)

10.3 (5.6)

15.4 (7.3)

0.004

0.005

0.012

0.004

Weight (kg)

68.4 (10.0)

64.8 (10.8)

65.1 (8.8)

63.7 (9.1)

65.9 (6.2)

64.2 (6.2)

65.2 (13.4)

66.2 (13.9)

< .001

0.098

0.012

0.059

BMI (kg/m2)

27.5 (3.0)

26.1 (3.4)

26.6 (3.8)

26.0 (4.0)

25.8 (2.2)

25.1 (2.3)

25.9 (3.7)

26.2 (3.9)

0.001

0.084

0.015

0.045

LM (kg)

37.9 (5.6)

37.3 (5.6)

38.1 (4.8)

37.9 (4.9)

38.2 (3.0)

37.5 (3.5)

39.3 (8.0)

38.6 (8.4)

0.092

0.535

0.113

0.058

FMwb (kg)

28.4 (5.1)

25.5 (5.8)

24.9 (4.0)

23.8 (4.4)

25.7 (4.2)

24.7 (4.5)

24.6 (6.9)

26.2 (7.1)

0.001

0.022

0.034

0.003

FMAndroid (kg)

2.84 (0.6)

2.56 (0.8)

2.42 (0.5)

2.24 (0.4)

2.43 (0.5)

2.25 (0.4)

2.41 (0.8)

2.59 (0.7)

0.034

0.059

0.001

0.035

FMGynoid (kg)

3.65 (0.8)

3.47 (0.7)

3.32 (0.9)

3.18 (0.8)

3.48 (0.8)

3.35 (0.9)

3.27 (0.8)

3.46 (0.8)

0.001

0.070

0.186

0.105

VAT (kg)

1.83 (0.6)

1.45 (0.6)

1.44 (0.6)

1.20 (0.6)

1.47 (0.7)

1.31 (0.6)

1.62 (0.8)

1.70 (0.8)

0.004

0.029

0.058

0.413

SAT (kg)

2.67 (0.8)

2.33 (0.7)

2.07 (0.5)

2.00 (0.6)

2.18 (0.7)

2.12 (0.8)

2.12 (0.6)

2.18 (0.6)

0.011

0.159

0.396

0.478

Glucose fasting (mmol/L)

5.73 (0.5)

5.26 (0.6)

5.48 (0.9)

5.58 (0.8)

5.50 (0.7)

5.48 (0.3)

5.97 (0.5)

6.11 (0.7)

0.036

0.737

0.939

0.392

Glucose 2-h (mmol/L)

9.34 (2.2)

6.63 (1.3)

8.16 (1.5)

6.54 (3.0)

8.21 (1.3)

6.98 (2.1)

8.13 (1.1)

8.60 (2.7)

0.019

0.245

0.076

0.637

Insulin fasting (µIU/mL)

25.9 (15.4)

18.4 (10.6)

14.3 (11.5)

13.9 (8.3)

20.2 (8.1)

15.9 (4.5)

16.4 (10.8)

16.4 (12.0)

0.154

0.843

0.067

0.997

HBA1c (%)

6.19 (0.3)

6.07 (0.3)

6.07 (0.3)

6.13 (0.2)

5.83 (0.5)

5.7 (0.5)

6.52 (0.2)

6.45 (0.4)

0.280

0.673

0.354

0.666

Triglyceride (mmol/L)

2.05 (1.8)

1.40 (1.2)

1.76 (0.8)

1.51 (0.5)

2.62 (1.3)

2.14 (1.1)

2.01 (1.0)

2.24 (1.3)

0.021

0.332

0.195

0.555

Cholesterol (mmol/L)

6.00 (0.7)

5.19 (0.9)

5.12 (0.9)

4.85 (0.6)

6.19 (1.2)

5.18 (0.6)

6.06 (0.9)

6.22 (0.7)

0.040

0.456

0.071

0.752

ALT (U/L)

24.0 (11.7)

16.3 (5.6)

22.6 (16.0)

18.6 (10.3)

24.6 (11.7)

22.6 (9.9)

18.7 (8.5)

30.7 (15.3)

0.232

0.533

0.511

0.116

AST (U/L)

27.5 (4.2)

19.5 (7.1)

24.4 (12.4)

23.5 (9.8)

24.7 (6.7)

23.0 (7.5)

24.6 (7.2)

28.4 (7.0)

0.081

0.887

0.663

0.496

VO2max (mL/min/kg)

13.7 (4.9)

18.0 (3.9)

16.6 (3.9)

19.8 (3.1)

15.9 (4.5)

25.0 (2.9)

17.9 (4.2)

21.1 (5.3)

0.041

0.002

 < 0.001

0.151

  1. Variables are presented as mean (SD). P values are based on a paired t test
  2. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index; ELCD: Exercise plus low carbohydrate diet intervention; Ex: Exercise intervention; FMandroid: Android fat mass; FMgynoid: Gynoid fat mass; FMwb: Total body fat mass; HBA1c: Glycated hemoglobin; HFC: Hepatic fat content; LCD: Low carbohydrate diet; LM: Total body lean mass; No: No intervention; SAT: Abdominal subcutaneous fat content; VAT: Abdominal visceral fat content; VO2max: Maximal oxygen uptake